top of page

Submission of Manuscript 

Aims & Scope

JCRM invites submissions that address the full spectrum of aesthetic and regenerative health. We prioritize original, timely contributions that advance clinical techniques, enhance safety profiles, and explore the psychosocial aspects of patient care.

Cosmetic Medicine & Aesthetic Procedures: 

Novel techniques, clinical outcomes, minimally invasive interventions, and safety assessments

Anti-Aging Science: 

Clinical, molecular, and metabolic approaches to aging and longevity.

Regenerative Therapies: 

  • Cutting-edge research in stem cells, platelet-rich plasma (PRP), growth factors, and exosome therapies.

Interdisciplinary Topics: 

  • The convergence of dermatology, plastic surgery, and allied health sciences.

Tissue Engineering:

  • Biomaterials, scaffolds, and their applications in soft tissue reconstruction and aesthetics.

Guideline for Manscript 

Manuscript Types

The Journal of Cosmetic and Regenerative Medicine (JCRM) welcomes submissions that advance the fields of cosmetic medicine, regenerative therapies, aesthetic procedures, tissue engineering, stem cell research, anti-aging interventions, and related interdisciplinary topics. Manuscripts must be original, timely, and contribute meaningfully to clinical practice, research, or education in these areas. All submissions should adhere to relevant EQUATOR Network reporting guidelines (e.g., CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews). A Data Sharing Statement is required for research articles unless otherwise noted.

JCRM accepts the following article types, adapted from established guidelines in similar specialty journals. Presubmission inquiries are encouraged for certain types (e.g., Consensus Statements) via email to the editorial office. 

Research

  • Original Investigation These reports include clinical trials, meta-analyses, intervention studies, cohort studies, case-control studies, epidemiologic assessments, surveys with high response rates, cost-effectiveness analyses, decision analyses, studies of screening and diagnostic tests, or other observational studies relevant to cosmetic and regenerative medicine. Manuscripts should specify the study type (e.g., randomized clinical trial, cohort study) and include the objective or hypothesis, design and methods (including setting, dates, participants, inclusion/exclusion criteria), interventions or exposures, main outcomes and measures, results, discussion with context to existing literature and limitations, and conclusions. Data must be original and not previously published.

    • Word limit: 3000 words (excluding abstract, tables, figures, acknowledgments, references, and online-only material).

    • Abstract: Structured, ≤350 words, with headings (Importance, Objective, Design, Setting, and Participants, Intervention(s) or Exposure(s), Main Outcomes and Measures, Results, Conclusions and Relevance). Trial registration number required if applicable.

    • Key Points: Required; 3 bullet points (Question, Findings, Meaning), ≤100 words total.

    • Other requirements: ≤5 tables and/or figures; ≤50 references; follow EQUATOR guidelines.

  • Brief Report Short reports of original studies or evaluations, or unique, first-time reports of clinical case series (at least 3 cases) with relevance to cosmetic or regenerative medicine. Single case reports should be submitted as Observations. Extensive laboratory evaluations (e.g., genetic or biomolecular analysis) may be included.

    • Word limit: 1200 words (excluding abstract, tables, figures, acknowledgments, references, and online-only material).

    • Abstract: Structured, same format as Original Investigation.

    • Key Points: Required; same as Original Investigation.

    • Other requirements: ≤3 tables and/or figures; ≤15 references; follow EQUATOR guidelines.

  • Research Letter Concise, focused reports of original research, which may include any of the study types listed under Original Investigation. These should not duplicate other material published or submitted. Structure as Introduction, Methods, Results, and Discussion.

    • Word limit: 600 words.

    • Abstract: None.

    • Key Points: None.

    • Other requirements: ≤6 references; ≤2 small tables and/or figures; follow EQUATOR guidelines.

Clinical Review and Education

  • Systematic Review (without meta-analysis) Critical assessments of the literature and data sources pertaining to clinical topics in cosmetic and regenerative medicine, such as etiology, diagnosis, prognosis, therapy, or prevention. Reviews should be evidence-based, balanced, and patient-oriented, addressing a focused question. Systematic reviews with meta-analysis should be submitted as Original Investigations. Include a PRISMA-style flow diagram as an online supplement and a table rating the quality of included studies or evidence. Subtitle: "A Systematic Review."

    • Word limit: 3000 words (excluding abstract, tables, figures, acknowledgments, references, and online-only material).

    • Abstract: Structured, ≤350 words, with headings (Importance, Objective, Evidence Review, Findings, Conclusions and Relevance).

    • Key Points: Required; same as Original Investigation.

    • Other requirements: ≤5 tables and/or figures; 50-75 references; follow PRISMA or equivalent EQUATOR guidelines.

  • Consensus Statement Reports generated from a consensus conference or expert panel on a disease, public health policy, or therapeutic intervention in cosmetic or regenerative medicine, often providing recommendations or policy statements. Presubmission inquiry required.

    • Word limit: 3500 words (excluding abstract, tables, figures, references, and online-only material).

    • Abstract: Structured, same as Systematic Review.

    • Key Points: Required; same as Original Investigation.

    • Other requirements: ≤5 tables and/or figures; 50-75 references; follow ACCORD or equivalent reporting guidelines.

  • Special Communication Scholarly, thorough, well-referenced, and evidence-based manuscripts on important issues in clinical medicine, public health, health policy, or medical research related to cosmetic and regenerative medicine. These are published infrequently.

    • Word limit: 3000 words (excluding tables, figures, and references).

    • Abstract: Structured, same as Systematic Review.

    • Key Points: None.

    • Other requirements: ≤4 tables and/or figures; ≤50 references.

  • Clinicopathological Challenge Presents a real patient scenario about a specific condition in cosmetic or regenerative medicine, including a clinical image. Includes a "What Is Your Diagnosis?" section with 4 single-phrase plausible treatment or diagnostic options (one preferred). Case presentation ≤250 words; discussion 500-600 words, with evidence-based explanations. Patient permission may be required for identifiable information.

    • Word limit: Total text ≤850 words for case, question, answers, and discussion.

    • Abstract: None.

    • Key Points: None.

    • Other requirements: ≤3 small figures (no insets); ≤10 references; ≤3 authors.

  • Images in Cosmetic and Regenerative Medicine A visual image of an interesting and unique observation in cosmetic or regenerative medicine, accompanied by a brief description of the clinical issue. Aims to enhance understanding of pathophysiology for improved diagnosis or treatment. Patient permission may be required.

    • Word limit: 500 words.

    • Abstract: None.

    • Key Points: None.

    • Other requirements: 1-2 images/figures; ≤4 references; ≤3 authors; no online-only material.

Opinion

  • Viewpoint Succinct opinion pieces on topics of immediate importance to patient care or professional issues in cosmetic and regenerative medicine (e.g., clinical practice, public health, research, ethics, or policy). These should be scholarly and focused, without unpublished data. JCRM encourages submissions from diverse authors.

    • Word limit: 1200 words (or 1000 words if including 1 small table or figure).

    • Abstract: None.

    • Key Points: None.

    • Other requirements: ≤7 references; ≤4 authors (≤2 affiliations per author).

Correspondence

  • Letter to the Editor Letters discussing a recent JCRM article; must be received within 4 weeks of the article's print publication. Should not duplicate other material or include unpublished data.

    • Word limit: 400 words.

    • Abstract: None.

    • Key Points: None.

    • Other requirements: ≤5 references (including the discussed article); ≤3 authors.

  • Letter in Reply Replies by authors of original articles to letters regarding their work.

    • Word limit: 500 words.

    • Abstract: None.

    • Key Points: None.

    • Other requirements: ≤6 references; ≤3 authors.

Observation

  • Observation Reports of 1-2 complicated and unique cases in cosmetic or regenerative medicine, with an emphasis on novel therapeutic or management approaches, unreported associations, or complications. Include high-quality clinical images (e.g., skin, tissue, or histopathologic). Patient permission may be required.

    • Word limit: 600 words (excluding acknowledgments, tables, figures, and references).

    • Abstract: None.

    • Key Points: None.

    • Other requirements: ≤6 references; ≤2 small tables/figures; no online-only material; ≤7 authors.

For all submissions, ensure compliance with JCRM's ethical policies, including disclosure of conflicts of interest, authorship criteria, and human/animal subjects protections. Online-only supplements are permitted for additional data. The format of reference quotation we adopt is Vancouer Style. Contact the editorial office for any questions.


Email: info@jcrmjournal.com

 

稿件類型 (刊登語言只支持英文發佈) 

《美容醫學與再生醫學雜誌》(Journal of Cosmetic and Regenerative Medicine, JCRM)歡迎投稿能夠推動化妝品醫學、再生治療、美學程序、組織工程、幹細胞研究、抗衰老干預以及相關跨學科領域發展的稿件。稿件必須具有原創性、時效性,並對臨床實踐、研究或教育產生有意義的貢獻。所有投稿應遵守相關 EQUATOR Network 報告指南(例如 CONSORT 用於隨機試驗、STROBE 用於觀察性研究、PRISMA 用於系統評價)。研究類文章需附上數據共享聲明(Data Sharing Statement),除非另有說明。

JCRM 接受以下稿件類型(參考同類專業期刊的成熟指南)。某些類型(如共識聲明)建議提前提交預查詢(presubmission inquiry),可通過電子郵件聯繫編輯部。

研究類(Research)

  • 原創研究(Original Investigation) 包括隨機臨床試驗、薈萃分析、干預研究、隊列研究、病例對照研究、流行病學評估、高回應率調查、成本效益分析、決策分析、篩查與診斷測試研究,或其他與化妝品及再生醫學相關的觀察性研究。稿件需明確標註研究類型,並包括:研究目標或假設、設計與方法(包括研究地點、時間、參與者、入選/排除標準)、干預或暴露因素、主要結局指標、結果、討論(置於現有文獻背景中並說明局限性)以及結論。數據必須為原創且未曾發表。

    • 字數限制:3000 字(不含摘要、表格、圖表、致謝、參考文獻及僅在線補充材料)。

    • 摘要:結構化,≤350 字,包含以下標題(重要性、目的、設計、場景與參與者、干預或暴露、主要結局指標、結果、結論與意義)。如為試驗,需提供註冊號。

    • 要點(Key Points):必須提供;3 條要點(問題、發現、意義),總字數 ≤100 字。

    • 其他要求:≤5 個表格和/或圖表;≤50 條參考文獻;遵守 EQUATOR 指南。

  • 簡短報告(Brief Report) 原創研究或評估的簡短報告,或首次報告的臨床病例系列(至少 3 例)且與化妝品或再生醫學相關。單一病例報告應提交為 Observation。允許包含廣泛的實驗室評估(如遺傳或生物分子分析)。

    • 字數限制:1200 字(不含摘要、表格、圖表、致謝、參考文獻及僅在線補充材料)。

    • 摘要:結構化,同 Original Investigation。

    • 要點(Key Points):必須提供,同上。

    • 其他要求:≤3 個表格和/或圖表;≤15 條參考文獻;遵守 EQUATOR 指南。

  • 研究快訊(Research Letter) 原創研究的簡潔、聚焦報告,可包含 Original Investigation 列出的任何研究類型。不得重複已發表或已投稿的其他材料。結構為引言、方法、結果和討論。

    • 字數限制:600 字。

    • 摘要:無。

    • 要點:無。

    • 其他要求:≤6 條參考文獻;≤2 個小型表格和/或圖表;遵守 EQUATOR 指南。

臨床評價與教育類(Clinical Review and Education)

  • 系統評價(無薈萃分析)(Systematic Review without meta-analysis) 對化妝品與再生醫學臨床主題(如病因、診斷、預後、治療或預防)的文獻與數據來源進行批判性評估。應基於證據、平衡、以患者為導向,並針對特定問題。帶薈萃分析的系統評價應提交為 Original Investigation。需附 PRISMA 流程圖(作為在線補充)及納入研究的質量評級表。副標題:「系統評價」。

    • 字數限制:3000 字(不含摘要、表格、圖表、致謝、參考文獻及僅在線補充材料)。

    • 摘要:結構化,≤350 字,包含(重要性、目的、證據評價、發現、結論與意義)。

    • 要點:必須提供,同 Original Investigation。

    • 其他要求:≤5 個表格和/或圖表;50-75 條參考文獻;遵守 PRISMA 或等效 EQUATOR 指南。

  • 共識聲明(Consensus Statement) 由共識會議或專家小組針對疾病、公共衛生政策或治療干預生成的報告,常提供推薦或政策建議。需提前提交預查詢。

    • 字數限制:3500 字(不含摘要、表格、圖表、參考文獻及僅在線補充材料)。

    • 摘要:結構化,同 Systematic Review。

    • 要點:必須提供。

    • 其他要求:≤5 個表格和/或圖表;50-75 條參考文獻;遵守 ACCORD 或等效報告指南。

  • 特別通訊(Special Communication) 關於化妝品與再生醫學領域臨床醫學、公共衛生、健康政策或醫學研究重要問題的學術性、全面、參考充分且基於證據的稿件。此類稿件發表頻率有限。

    • 字數限制:3000 字(不含表格、圖表及參考文獻)。

    • 摘要:結構化,同 Systematic Review。

    • 要點:無。

    • 其他要求:≤4 個表格和/或圖表;≤50 條參考文獻。

  • 臨床病理挑戰(Clinicopathological Challenge) 呈現真實患者病例,涉及化妝品或再生醫學特定情況,並附臨床圖像。包含「您的診斷是什麼?」部分,提供 4 個單詞短語的可信診斷或治療選項(其中一個為首選)。病例描述 ≤250 字;討論 500-600 字,提供基於證據的解釋。患者可識別信息需獲得許可。

    • 字數限制:總文字 ≤850 字(含病例、問題、答案及討論)。

    • 摘要:無。

    • 要點:無。

    • 其他要求:≤3 個小型圖表(無插圖);≤10 條參考文獻;≤3 名作者。

  • 化妝品與再生醫學圖像(Images in Cosmetic and Regenerative Medicine) 展示有趣且獨特的臨床圖像,附簡短臨床問題描述。旨在提升對病理生理的理解,從而改善診斷或治療。患者可識別信息需獲得許可。

    • 字數限制:500 字。

    • 摘要:無。

    • 要點:無。

    • 其他要求:1-2 張圖像;≤4 條參考文獻;≤3 名作者;無僅在線補充材料。

觀點類(Opinion)

  • 觀點(Viewpoint) 針對患者照護或化妝品與再生醫學專業問題的簡潔意見文章(例如臨床實踐、公共衛生、研究、倫理或政策)。應具學術性且聚焦,不得包含未發表數據。鼓勵多元作者投稿。

    • 字數限制:1200 字(若含 1 個小型表格或圖表,則為 1000 字)。

    • 摘要:無。

    • 要點:無。

    • 其他要求:≤7 條參考文獻;≤4 名作者(每位作者 ≤2 個隸屬機構)。

通信類(Correspondence)

  • 致編輯信(Letter to the Editor) 討論 JCRM 近期文章的信件,須於該文章印刷版發表後 4 週內提交。不得重複其他材料或包含未發表數據。

    • 字數限制:400 字。

    • 摘要:無。

    • 要點:無。

    • 其他要求:≤5 條參考文獻(含所討論文章);≤3 名作者。

  • 作者回覆信(Letter in Reply) 原文章作者對讀者來信的回覆。

    • 字數限制:500 字。

    • 摘要:無。

    • 要點:無。

    • 其他要求:≤6 條參考文獻;≤3 名作者。

觀察類(Observation)

  • 觀察報告(Observation) 報告 1-2 例複雜或獨特病例,強調化妝品或再生醫學的新穎治療/管理方法、未報告的關聯或併發症。需附高質量臨床圖像(皮膚、組織或病理)。患者可識別信息需獲得許可。

    • 字數限制:600 字(不含致謝、表格、圖表及參考文獻)。

    • 摘要:無。

    • 要點:無。

    • 其他要求:≤6 條參考文獻;≤2 個小型表格/圖表;無僅在線補充材料;≤7 名作者。

所有投稿均需遵守 JCRM 的倫理政策,包括利益衝突披露、作者資格標準以及人體/動物受試者保護規定。允許使用在線補充材料提供額外數據。我们采用的参考文献引用格式为温哥华格式 (Vancouver Style)。如有任何疑問,請聯繫編輯部。

Email: info@jcrmjournal.com
 

+852-61880835 / +852-25656468 

  • Shop 8, G/F, Kam Fai Building, 16A Waterloo Road, Yau Ma Tei, Kowloon, 
    Hong Kong ; or  

    7/F, 16 Stanley Street, Central 
    Hong Kong 
     

  • Unit C-2-20, DaMen USJ Komersial, Persiaran Kewajipan, Usj 1, 47500 Subang Jaya, Selangor Malaysia
    Malaysia 
     

  • 11th Floor, 735 Eonju-ro, Gangnam-gu, Seoul
    Republic of Korea

  • Facebook
  • Instagram
  • X
  • TikTok

ISSN 3107-2933

© 2026 by JCRM. All Rights Reserved.

 

bottom of page